RenovoRx, Inc.RNXTNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+7.2%
5Y CAGR+30.8%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+7.2%/yr
Annual compound
5Y CAGR
+30.8%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.8x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$12.25M+11.2%
2024$11.01M-3.4%
2023$11.40M+14.5%
2022$9.95M+75.5%
2021$5.67M+77.0%
2020$3.20M-17.8%
2019$3.90M-